Search results
2 mar 2024 · Medications that act by sodium channel blockade have various clinical applications. Broadly, they include Vaughn Williams Class 1 antiarrhythmics, local anesthetics, and many medications to treat neuropathic pain, including tricyclic antidepressants (TCA), anticonvulsants, and cocaine. Specific examples include quinidine and procainamide (class 1A antiarrhythmics), lidocaine, mexiletine, and ...
1 lip 2020 · Salt toxicity is a rare form of hypernatremia that typically occurs after a single massive ingestion of salt over a short period of time (minutes/hours). It is a dangerous imbalance capable of causing significant neurological injury; quick recognition of salt toxicity is crucial to allow treatment before permanent brain injury occurs.
1 kwi 2020 · It is a dangerous imbalance capable of causing significant neurological injury; quick recognition of salt toxicity is crucial to allow treatment before permanent brain injury occurs. The...
29 maj 2023 · Hypernatremia occurs when the balance of water and sodium in your blood is off: there's either too much sodium or not enough water. This can happen when too much water is lost or too much...
26 kwi 2021 · In a patient who overdosed on a medication known to block sodium channels (e.g., TCA), the EKG should be repeated frequently to allow for early detection of sodium channel toxicity. terminal right-axis deviation (RAD) with tall R-aVR. The key to diagnosing sodium channel blockade is recognition of terminal rightward axis deviation.
14 cze 2023 · Many drugs cause hyponatremia, and the most common include: Illicit drugs such as methylenedioxymethamphetamine (MDMA or ecstasy). [6] Hyponatremia is the most common electrolyte disorder, with a prevalence of 20% to 35% among hospitalized patients.
17 maj 2022 · Certain drugs. Medications that increase your risk of hyponatremia include thiazide diuretics as well as some antidepressants and pain medications. In addition, the recreational drug Ecstasy has been linked to fatal cases of hyponatremia.
